Greenwood Capital Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+1,773
New +$313K 0.02% 278
2026
Q1
– Sell
-42,530
Closed -$6.02M – 287
2025
Q4
$6.02M Sell
42,530
-7,626
-15% -$866K 0.65% 50
2025
Q3
$4.07M Buy
+50,156
New +$3.87M 0.47% 70
2023
Q2
– Sell
-22,375
Closed -$4.95M – 239
2023
Q1
$4.95M Buy
+22,375
New +$5.51M 0.71% 52

Other funds holding ALB

Greenwood Capital Associates's ALB Position: Q2 2026 in Review

Greenwood Capital Associates opened a new position in Albemarle (ALB) in Q2 2026: 1,773 shares worth $239K. The stake represents 0.02% of the portfolio and ranks #278 among its holdings. This is a return to the name: Greenwood Capital Associates previously reported a position in ALB as recently as Q4 2025.

Greenwood Capital Associates first reported a position in ALB in Q1 2023 and has held it in 4 quarters since. The position peaked at $6.02M in Q4 2025. 945 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Greenwood Capital Associates held 1,773 shares of Albemarle worth $239K as of Q2 2026.
  • Albemarle was a new Greenwood Capital Associates position in Q2 2026.
  • Albemarle made up 0.02% of Greenwood Capital Associates's portfolio in Q2 2026, its #278 holding.
  • Greenwood Capital Associates first reported a position in Albemarle in Q1 2023 and has held it in 4 quarters since.
  • Greenwood Capital Associates's Albemarle position peaked at $6.02M in Q4 2025.
  • 945 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.